Iopasen (Iopamidol)

Iopamidol works by delivering iodine atoms, which have a high atomic number, into the bloodstream. These atoms increase X‑ray attenuation, creating a contrast between blood‑filled structures and surrounding tissues. The resulting enhanced images allow clinicians to better assess vascular anatomy and organ morphology during radiographic examinations.

The dose of Iopasen is individualized and determined by the prescribing physician based on the specific imaging study, patient weight, renal function, and clinical requirements. Healthcare professionals calculate the appropriate volume and concentration to achieve optimal image quality while minimizing potential adverse effects.

The safety of Iopasen in pregnancy or while breastfeeding has not been definitively established. Use is generally reserved for situations where the diagnostic benefit outweighs potential risks. Clinicians should evaluate the necessity of the procedure and consider alternative imaging methods when possible.

To order Iopasen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Iopasen contains iopamidol, a low‑osmolality, non‑ionic iodinated contrast medium. Compared with older high‑osmolality agents, it typically offers a lower incidence of adverse reactions and better patient tolerance. Relative to other low‑osmolality agents, its safety profile and imaging efficacy are comparable, with selection often based on institutional preference, cost, and specific procedural requirements.

Iopasen should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from direct sunlight, moisture, and extreme temperature fluctuations. Do not freeze the solution, and ensure the container remains sealed until use to maintain sterility and stability.

Iopasen is administered intravenously by a qualified healthcare professional. The solution is injected through a peripheral or central vein, typically using a power injector or manual bolus, depending on the imaging protocol. Proper aseptic technique and appropriate injection rate are essential to achieve optimal contrast enhancement and reduce the risk of adverse events.

The most serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury especially in patients with pre‑existing renal impairment, and cardiovascular events like hypotension or arrhythmias. Prompt recognition and management of these reactions are critical, and patients should be monitored closely during and after administration.

Iopasen should be avoided in individuals with a known hypersensitivity to iopamidol or other iodinated contrast media, those with severe renal dysfunction where alternative imaging is possible, and patients who have experienced prior severe reactions to contrast agents. Clinicians must assess each patient’s medical history before administration.